“showed a trend”

Compared with cardiac MRI, 4D-MSPECT of gated F-18 FDG PET/CT showed a trend towards higher LV EDV with increasing magnitude of LV EDV, as noted on the Bland-Altman plot (y = 0.14x−32.26, P = 0.0007) ( Fig. 3D ).

Analysis by annual percentage change (APC) identified four segments of interrupted trends for preterm live births, all with statistical significance: the 2000–2010 period showed an increasing trend (APC: 2.23; p = 0.0008); the 2010–2013 period demonstrated an accelerated growth (APC: 12.77; p = 0.0008); the 2013–2016 period showed a trend reversal with a decline (APC: −4.75; p = 0.0024); and the 2016–2023 period indicated a resumption of growth (APC: 1.78; p < 0.0001).

As shown in Figure 4 A, decreasing number of ANCs showed a trend of a negative correlation with elevated levels of CXCL1 (r = −0.2378, p = 0.0008), CXCL2 (r = −0.2542, p = 0.0051), and IL-6 (r = −0.3428, p = 0.0001).

An intronic marker in IRF6 (rs2073487) also showed a trend for association with complete left cleft lip/palate (P = 0.0009).

Specifically, LTRs with infection showed a trend toward reduced α-diversity ( Fig. 5 A) and pronounced shifts in β-diversity ( P = 0.001; Fig. 5 B), reflecting a distinct microbial community composition.

However, despite the large amount of inter-category differences, the median PSI of each layer showed a trend of increase along the hierarchy in both Conv and FC layers, respectively (AlexNet: Kendall's tau = 0.40, p < 0.001; VGG11: Kendall's tau = 0.36, p < 0.001).

The clemastine-treated group showed a trend of reduced footfalls, which reached significance (p < 0.001).

Patients with moderate and severe TR showed a trend towards a lower BMI (TR 0 29.8±5.5 kg/m 2 vs TR 1 27.9±4.9 kg/m 2 , TR 2 26.7±5.1 kg/m 2 and TR 3 26.9±5.0; p<0.001).

Expectedly, all CEQ subscales except the Death subscale correlated negatively (or showed a trend towards negative correlations), with the strongest effect (r = -.36, p < .001) for Fear.

Patients with heart failure also showed a trend toward higher risk at overall follow-up ( HR = 1.61 p < 0.001).

The second post-contrast imaging time showed a trend of higher ECV-values than the first time point, with an absolute deviation of 0.014 ± 0.016 for MOLLI ( p < 0.001), 0.008 ± 0.013 for SAPPHIRE ( p < 0.02), and 0.005 ± 0.020 for SASHA ( p = 0.24).

We found that with the increase of BMI*ABSI quartiles, all baseline metrics of subjects showed a trend of change (all P < 0.001).

In contrast, the >60 years group showed a trend toward higher risk (unadjusted HR = 1.032, 95% CI 1.012–1.053, P = 0.001), which lost statistical significance after adjustment (adjusted HR = 1.015, 95% CI 0.994–1.037, P = 0.151).

Additionally, infections with typical bacteria were more common in patients with chronic lung disease ( p = 0.029), and typical bacterial infections showed a trend towards a higher prevalence with older age ( p = 0.001).

The results of this study showed a trend of improvement in the CCF ( p = 0.001) and CCRR ( p = 0.021) scores of the three CPR tests (10-min uninterrupted, CPR-10s, and CPR-20s) with increases in the interruption time.

Technology-supported treatments for depression showed a trend toward reduced depressive symptoms (SMD=–0.58, 95% CI –0.71 to –0.45; P <.001) ( Figure 4 ).

On the other hand, a high dose of 100 μg/ml already showed a trend towards loss of osteogenic commitment (Control = 11.3 ± 1.4%, TG-VEGF 0.01 = 10.3 ± 0.7%, TG-VEGF 0.1 = 27.9 ± 2.8%, TG-VEGF 100 = 6.1 ± 2.0%; p < 0.001 TG-VEGF 0.1 vs Control).

The H2 blocker group also showed a trend toward poorer PFS (HR = 1.987, P < 0.001) and OS compared with those without antacid use (HR = 3.380, P = 0.226).

Coughing, which had the highest baseline occurrence rate and severity, showed a trend of gradual attenuation with ongoing immunotherapy‐based combination treatment ( p < 0.001).

HCCs with a typical enhancement pattern on CT or MRI showed a trend toward Type III curves ( P < .001).

5 ) but showed a trend towards shorter T2* values with increasing fat concentration stratified by ACR categories ( p < .001).

Comparison of participants grouped according to 5 mmHg increments of systolic IAD showed a trend towards rising age, systolic and diastolic BPs, rising heart‐rate, and rising prevalence of diabetes and hypertension ( p < .001 for all comparisons).

The UDVA value showed a trend of improvement in the control group ( p < 0.001), and the changes to SE and residual myopia were significantly lower in the control group (both p < 0.001).

Serum ferritin levels showed a trend towards increasing with age in the both AGA and SGA groups ( P <0.001).

The median overall survival in these patients receiving standard radiotherapy and concomitant temozolomide chemotherapy showed a trend towards better survival in group with methylated MGMT promoter (p < 0.001).